GST rate modification: Kerala updates SGST schedules to reclassify certain pharmaceuticals, snacks and seat tariff entries. Kerala amends its SGST notification to add Trastuzumab Deruxtecan, Osimertinib and Durvalumab to List 1; inserts tariff 1905 90 30 for extruded or expanded savoury/salted products into Schedule II; broadens Schedule III descriptions to include extruded/expanded savoury or salted products and substitutes Serial No. 435A to redefine coverage of seats under heading 9401 excluding aircraft and motor vehicle seats; and inserts Schedule IV entry 210A (9401 20 00) for motor vehicle seats. Amendments are effective 10 October 2024.
Cases where this provision is explicitly mentioned in the judgment/order text; may not be exhaustive. To view the complete list of cases mentioning this section, Click here.
Provisions expressly mentioned in the judgment/order text.
GST rate modification: Kerala updates SGST schedules to reclassify certain pharmaceuticals, snacks and seat tariff entries.
Kerala amends its SGST notification to add Trastuzumab Deruxtecan, Osimertinib and Durvalumab to List 1; inserts tariff 1905 90 30 for extruded or expanded savoury/salted products into Schedule II; broadens Schedule III descriptions to include extruded/expanded savoury or salted products and substitutes Serial No. 435A to redefine coverage of seats under heading 9401 excluding aircraft and motor vehicle seats; and inserts Schedule IV entry 210A (9401 20 00) for motor vehicle seats. Amendments are effective 10 October 2024.
Full Summary is available for active users!
Note: It is a system-generated summary and is for quick reference only.
TaxTMI 
of 
TaxTMI 
